Skip to content

Opko Health OPK Equity Method Investments

Equity Method Investments at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$134M0.0%
HRO
HarrowHROW
$0
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$31.52M

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's equity method investments?
Opko Health (OPK) reported equity method investments of $10.53M in Q1 2026.
How has Opko Health's equity method investments changed year-over-year?
Opko Health's equity method investments decreased by 17.4% year-over-year, from $12.75M to $10.53M.
What is the long-term trend for Opko Health's equity method investments?
Over 5 years (2020 to 2025), Opko Health's equity method investments has grown at a -2.1% compound annual growth rate (CAGR), from $15.73M to $14.17M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.